DOI QR코드

DOI QR Code

Hepatoprotective Activity of Fermented Curcuma longa L. on Galactosamine-Intoxicated Rats

발효울금의 갈락토사민 투여에 의한 흰쥐의 간독성에 대한 보효 효과

  • Received : 2012.04.16
  • Accepted : 2012.05.23
  • Published : 2012.06.30

Abstract

In this study, the general components and minerals of fermented Curcuma longa L. (FC) by Aspergillus oryzae were examined as well as the hepatoprotective effects of FC on acute hepatotoxicity induced by a single dose of galactosamine (GalN, 650 mg/kg body weight (b.w.)). The FC was found to consist of 0.15% moisture, 4.68% crude fat, 4.35% crude protein, 6.92% crude fiber, and 6.83% crude ash. The P, Ca, and Mg levels in FC were also quantitatively analyzed. Male Sprague-Dawley rats were divided into six groups; nontreated control, GalN, 150 mg/kg b.w. of silymarin plus GalN, 30 mg/kg b.w. of FC plus GalN, 100 mg/kg b.w. of FC plus GalN, and 300 mg/kg b.w. of FC plus GalN. Pretreatment 300 mg/kg b.w. of FC during 14 days significantly decreased the increased in aspartate aminotransferase, alanine amino transferase, and triglyceride (TG) induced by GalN. Severe liver damage, hepatocellular necrosis, infiltration of inflammatory cells, and councilman body necrosis on histopathological liver tissues were observed in GalN treated rats. Administration of 300 mg/kg b.w. of FC significantly decreased the degree of live damage. These results suggest that FC displays hepatoprotective activity and FC was able to lower the TG levels in serum; thus, FC may serve as a useful material for health food and clinical conditions associated with liver disease.

본 연구는 울금의 산업적 실용화를 극대화시키기 위해 Aspergillus oryzae를 이용하여 산업용 규격에서 생산된 발효울금의 일반성분 및 미량성분 분석과 발효울금을 이용하여 동물모델에서 14일간 예비 투여하고 GalN으로 급성 간독성을 유발한 후 혈액 중 간기능 지표물질의 변화 및 간조직의 조직학적 관찰을 통해 GalN로 유발된 급성 간독성에 발효울금의 간기능 보호효과를 평가하고자 하였다. 발효울금의 일반성분은 수분 0.15%, 조지방 4.68%, 조단백 4.35%, 조섬유 6.92%, 조회분은 6.83%로 분석되었다. 발효울금의 미량성분은 P, Mg, Ca 순으로 분석되었다. 간기능 지표효소인 AST와 ALT의 활성은 발효울금 300 mg/kg/day과 silymarin 150 mg/kg/day를 투여한 군에서 GalN만을 투여한 군과 비교하여 통계적으로 유의한 결과를 나타내어 발효울금 300 mg/kg/day의 예비 투여는 GalN에 대한 급성 간독성에 대해 보호효과를 갖으며, 양성 대조군인 silymarin 150 mg/kg/day 투여와 비교하여 유사한 간독성 보호 활성을 갖는 것으로 나타났다. ALP의 경우 발효울금을 100 mg/kg/day로 투여한 군에서만 GalN만을 투여한 군과 통계적으로 유의한 감소를 나타났고 300 mg/kg/day 발효울금을 투여한 군과 silymarin 투여군은 통계적 유의차가 나타나지 않았다. 중성지방의 경우 발효울금 300 mg/kg/day 투여군만 GalN만을 투여한 군과 비교하여 통계적 유의차가 나타났으나 silymarin 투여군에서는 동일한 효과가 나타나지 않았다. GalN으로 유도된 급성 간독성의 조직병리학적 결과 GalN만을 투여한 군에서 세포괴사 및 침윤된 염증세포, 카운실만소체의 괴사가 심하게 나타났으며 300 mg/kg/day 발효울금 투여군과 150 mg/kg/day silymarin 투여군에서 간조직의 괴사 및 염증의 개선효과를 관찰할 수 있었다. 혈청 분석 및 조직병리학적 결과를 종합한 결과 GalN 유발 간독성에 대한 개선효과는 300 mg/kg/day 발효울금 투여군과 150 mg/kg/day silymarin 투여군에서 나타나는 것으로 판단할 수 있었다. 이러한 결과로부터 본 연구에서 사용한 Aspergillus oryzae로 발효하여 산업적 규격에서 생산된 발효울금은 간기능 저하 개선 기능을 갖는 새로운 기능성 소재로서 간질환과 관련된 다양한 기능성식품 개발에 이용될 수 있을 것으로 생각된다.

Keywords

References

  1. Korean National Statistical Office. 2010. Annual report on the cause of death statistics. p 6-7.
  2. Lim HK, Kim HS, Choi HS, Choi JW. 1999. Protective and therapeutie effects of Malloti cortex extract on carbon tetrachloride-and galactosamine-induced hepatotoxicity in rats. J Appl Pharmacol 7: 35-43.
  3. Murakmi T, Kim T, Nakamura H. 1998. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 8: 346-358. https://doi.org/10.1002/jmri.1880080214
  4. Ramakrishnan G, Augustine TA, Jagan S, Vinodhkumar R, Devaki T. 2007. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp Oncol 29: 39-44.
  5. Kang SK. 2007. Changes in Proximate composition, free amino acid, free sugar and vitamin of Curcuma longa L. and Curcuma atomatica Salib according to picking time. Korean J Food Preserv 14: 624-632.
  6. Cheon HJ, Park JG, Kang SK, Cai XF, Lee JJ, Lee SM. 2007. Hepatoprotective activities of curcumin, demethoxycurcumin and bisdemethoxycurcummin. Kor J Pharmacogn 38: 139-147.
  7. Kim TH, Son YK, Hwang KH, Kim MH. 2008. Effects of Angelica keiskei Koidzumi and tumeric extract supplement on serum lipid parameters in hypercholesterolemic diet or p-407-induced hyperlipidemic rats. J Korean Soc Food Sci Nutr 37: 708-713. https://doi.org/10.3746/jkfn.2008.37.6.708
  8. An BJ, Lee JY, Park TS, Pyeon JR, Bae HJ, Song MA, Baek EJ, Park JI, Son JH, Lee CE, Choi KI. 2006. Antioxidant activity and whitening effect of extraction conditions in Curcuma longa L. Korean J Medicinal Crop Sci 14: 168-172.
  9. Kang JK, Kang HJ, SE JH, Kim SO, Choi JH, Cho DY, Park CG, Lee HY. 2009. Effects of fermented tumeric (Curcuma longa) by Bacillus natto supplementation on liver function and serum lipid parameters in mice. J Korean Soc Food Sci Nutr 38: 430-435. https://doi.org/10.3746/jkfn.2009.38.4.430
  10. Korean Food Code. 2008. Korea Food & Drug Administration, Seoul, Korea. p 10-1-1, 10-1-6, 10-1-7, 10-1-27, 10-1-33, 10-1-58.
  11. Decker K, Keppler D. 1973. Galactosamine-induced liver injury. In Progress in Liver Disease. Grune and Stratton, New York, NY, USA. Vol 14, p 183.
  12. El-Mofty SK, Scrutton MC, Serroni A, Nicolini C, Faber JL. 1975. Early, reversible plasma membrane injury in galactosaminee- induced liver cell death. Am J Pathol 79: 579-595.
  13. Keppler D, Lesch R, Reutter W, Decker K. 1968. Experimental hepatitis induced by d-galactosaminee. Exp Mol Pathol 9: 279-290. https://doi.org/10.1016/0014-4800(68)90042-7
  14. Lesch R, Reutter W, Keppler D, Decker K. 1969. Liver restitution after acute galactosaminee hepatitis: autoradiographic and biochemical studies in rats. Exp Mol Pathol 12: 58-69.
  15. Miller EC, Miller JA. 1972. Hepatocarcinogenesis by chemicals. In Progress in Liver Disease. Grune & Stratton, New York, NY, USA. Vol 5, p 699.
  16. Maley F, Tarentino AL, McGarrahan JF, Giacco R. 1968. The metabolism of D-galactosaminee and N-acetyl-D-galactosaminee in rat liver. Biochem J 107: 637-644. https://doi.org/10.1042/bj1070637
  17. Yi KN, Kim JQ. 1988. Clinical chemistry. Euihakmunawhasa, Seoul, Korea. p 301-309.
  18. Park JY, Park CM, Kim JJ, Song YS. 2008. Hepatoprotective activity of dandelion (Taraxacum officinale) water extract against D-galactosamine-induced hepatitis in rats. J Korean Soc Food Sci Nur 37: 177-183. https://doi.org/10.3746/jkfn.2008.37.2.177
  19. Zieve L, Anderson WR, Dozeman R. 1988. Hepatic regenerative enzyme activity after diffuse injury with galactosamine, relationship to histological alteratios. J Lab Clin Med 115: 575-582.
  20. Kuhlmann WD, Wurster K. 1980. Correlation of histology and alpha 1-fetoprotein resurgence in rat liver regeneration after experimental injury by galactosamine. Virchows Arch A Pathol Histol 387: 47-57. https://doi.org/10.1007/BF00428428
  21. Yuk DY, Lee MY, Yun YP. 2004. Effect of green tea catechin on acute hepatotoxicity in rats. J Fd Hyg Safety 19: 105-111.

Cited by

  1. In Vitro Hepatoprotective Effects of Fermented Curcuma longa L. by Aspergillus oryzae against Alcohol-Induced Oxidative Stress vol.45, pp.6, 2016, https://doi.org/10.3746/jkfn.2016.45.6.812
  2. Hepatotoxicity Reducing Effect of Ethanol Extracts from Fermented Youngia denticulata Houtt Kitamura in Ethanol-treated Rats vol.26, pp.5, 2016, https://doi.org/10.17495/easdl.2016.10.26.5.389
  3. Acute Oral Toxicity Study of Ethanol Extract of Curcuma longa L. in Mice vol.24, pp.10, 2014, https://doi.org/10.5352/JLS.2014.24.10.1132
  4. Immunomodulatory Effects of Fermented Curcuma longa L. Extracts on RAW 264.7 Cells vol.43, pp.2, 2014, https://doi.org/10.3746/jkfn.2014.43.2.216
  5. Anti-Obesity Effect of Ethyl Acetate Fraction from 50% Ethanol Extract of Fermented Curcuma longa L. in 3T3-L1 Cells vol.43, pp.11, 2014, https://doi.org/10.3746/jkfn.2014.43.11.1681
  6. Quality Characteristics of Fish Paste Containing Curcuma longa L. Powder vol.25, pp.4, 2012, https://doi.org/10.9799/ksfan.2012.25.4.833
  7. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study vol.13, pp.1, 2013, https://doi.org/10.1186/1472-6882-13-58
  8. Quality Characteristics and Antioxidative Activities of Majakgwa added with Fermented Turmeric Powder vol.29, pp.3, 2013, https://doi.org/10.9724/kfcs.2013.29.3.223
  9. 간 독성에 대한 보석 호박 호박산의 간 보호 효과 vol.27, pp.8, 2017, https://doi.org/10.5352/jls.2017.27.8.896
  10. 진도산 울금(Curcuma longa L.)의 이화학적 특성 vol.28, pp.4, 2019, https://doi.org/10.5322/jesi.2019.28.4.403
  11. Curcuma longa: A treasure of medicinal properties vol.10, pp.2, 2020, https://doi.org/10.5667/cellmed.2020.0009